VE

Verge Genomics

YC S15

San Francisco, US · Founded 2015 · 50 employees · 5 known investors

vergegenomics.com ↗

Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease. The company applies frontier AI techniques to drug discovery for life sciences and pharmaceutical development.

Founders & leadership· Y Combinator alumni (S15)

Alice ZhanginCEO

ER

Emily RipkaHead of Product & Engineering

Investors · 5

BO

BOLD LongevityBoston

GR

Great Oaks Venture CapitalNew York · $50K – $500K

LI

Lifeforce CapitalChevy Chase

Y

Y CombinatorSan Francisco · $500K – $500K

WO

WorldQuant VenturesreportedOld Greenwich